Structures by: Pan Y. Z.
Total: 9
C38.5H33Cl3N2PtSi2
C38.5H33Cl3N2PtSi2
RSC Adv. (2015) 5, 80 65613
a=7.1264(4)Å b=38.160(2)Å c=14.3796(10)Å
α=90.00° β=96.337(4)° γ=90.00°
C41H35Cl2N2PtSi2
C41H35Cl2N2PtSi2
RSC Adv. (2015) 5, 80 65613
a=20.638(3)Å b=10.9657(16)Å c=19.312(3)Å
α=90.00° β=103.687(7)° γ=90.00°
C41.5H45Cl3N2PtSi2
C41.5H45Cl3N2PtSi2
Dalton transactions (Cambridge, England : 2003) (2013) 42, 36 13092-13100
a=12.1068(4)Å b=18.3651(7)Å c=21.0217(7)Å
α=74.111(2)° β=77.900(2)° γ=81.188(2)°
C42H45N3PtSi2
C42H45N3PtSi2
Dalton transactions (Cambridge, England : 2003) (2013) 42, 36 13092-13100
a=13.2821(3)Å b=30.6005(7)Å c=20.2538(4)Å
α=90.00° β=91.8230(10)° γ=90.00°
C40H41N2PtSi2,CHCl3
C40H41N2PtSi2,CHCl3
Dalton transactions (Cambridge, England : 2003) (2013) 42, 36 13092-13100
a=12.3245(5)Å b=18.1803(7)Å c=19.7378(8)Å
α=88.681(2)° β=74.458(2)° γ=79.431(2)°
C26H17BrN2Pt,2(CH2Cl2)
C26H17BrN2Pt,2(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 1 352-360
a=7.684(2)Å b=22.104(3)Å c=17.567(3)Å
α=90.00° β=95.756(2)° γ=90.00°
C26H17BrN2Pt,2(CHCl3)
C26H17BrN2Pt,2(CHCl3)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 1 352-360
a=7.7725(4)Å b=21.7699(12)Å c=18.8391(8)Å
α=90.00° β=94.510(2)° γ=90.00°
10-Ethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-10<i>H</i>-phenothiazine
C17H15N3OS
Acta Crystallographica Section E (2012) 68, 3 o649
a=7.6752(4)Å b=8.2913(4)Å c=12.9469(8)Å
α=84.870(4)° β=82.569(4)° γ=63.696(3)°
2-(5-Bromothiophen-2-yl)-5-[5-(10-ethylphenothiazin-3-yl)thiophen-2-yl]- 1,3,4-oxadiazole
C24H16BrN3OS3
Acta Crystallographica Section E (2012) 68, 5 o1383-o1384
a=7.4300(5)Å b=7.6019(5)Å c=22.1933(14)Å
α=89.315(4)° β=89.170(4)° γ=64.891(4)°